AG00I5IM

298-46-4 | 5H-Dibenz[b,f]azepine-5-carboxamide

AG00I5IM

SDS

COA

Price

$0.00

Add to Cart

Buy Now

WARNING This product is not for human or veterinary use.

CAS Number	298-46-4
Catalog Number	AG00I5IM(AGN-PC-07229O)
Chemical Name	5H-Dibenz[b,f]azepine-5-carboxamide
EC Number	206-062-7
IUPAC Name	benzo[b][1]benzazepine-11-carboxamide
InChI	InChI=1S/C15H12N2O/c16-15(18)17-13-7-3-1-5-11(13)9-10-12-6-2-4-8-14(12)17/h1-10H,(H2,16,18)
InChI Key	FFGPTBGBLSHEPO-UHFFFAOYSA-N
MDL Number	MFCD18071344
Molecular Formula	C15H12N2O
Molecular Weight	236.2686
SMILES	O=C(N1C2=CC=CC=C2C=CC3=CC=CC=C31)N
UNII	33CM23913M
Synonyms	Amizepine, Carbamazepine, Carbamazepine Acetate, Carbamazepine Anhydrous, Carbamazepine Dihydrate, Carbamazepine Hydrochloride, Carbamazepine L-Tartrate (4:1), Carbamazepine Phosphate, Carbamazepine Sulfate (2:1), Carbazepin, Epitol, Finlepsin, Neurotol, Tegretol, carbamazepine, 298-46-4, Tegretol, Carbamazepen, 5H-Dibenzo[b,f]azepine-5-carboxamide, Carbazepine, Finlepsin, Biston, Equetro, Carbamezepine, Tegretal, Epitol, 5H-Dibenz[b,f]azepine-5-carboxamide, Carbatrol, Neurotol, Timonil, Karbamazepin, Stazepine, Telesmin, Lexin, Tegretol-Xr, Carbamazepina, Carbamazepinum, Carbamazepin, Amizepin, Bipotrol, Teril, 5-Carbamyl-5H-dibenzo(b,f)azepine, 5-Carbamoyl-5H-dibenzo(b,f)azepine, Geigy 32883, 5H-Dibenz(b,f)azepine-5-carboxamide, Calepsin, Carnexiv, Stazepin, 5-Carbamoyl-5H-dibenz(b,f)azepine, benzo[b][1]benzazepine-11-carboxamide, 5-Carbamoyl-5H-dibenz[b,f]azepine, G 32883, G-32883, Carbamazepan, Carbelan, Sirtal, NSC 169864, Tegretol Cr, Carbamazepinum [INN-Latin], Carbamazepina [INN-Spanish], CHEBI:3387, UNII-33CM23913M, HSDB 3019, FFGPTBGBLSHEPO-UHFFFAOYSA-N, EINECS 206-062-7, CHEMBL108, BRN 1246090, 5-Carbamyldibenzo(b,f)azepine, MLS000069652, 5-Carbamoyldibenzo(b,f)azepine, CBZ, dibenzo[b,f]azepine-5-carboxamide, MFCD00005073, NSC169864, 33CM23913M, Carbamazepine, 98%, NCGC00015234-11, AK116064, CAS-298-46-4, SMR000058201, DSSTox_CID_2731, DSSTox_RID_76704, DSSTox_GSID_22731, Q-200792, Carbazepin, 5H-dibenzo[b,f]azepine-5-carboxamide;Oxcarbazepine IMpurity A, Amizepine, 2-azatricyclo[9.4.0.0^{3,8}]pentadeca-1(11),3(8),4,6,9,12,14-heptaene-2-carboxamide, SMR001227191, SR-01000000229, Carbatrol extended-release, Atretol, Trimonil, Neurotop retard, Novo-Carbamaz, Nu-Carbamazepine, Apo-Carbamazepine, Tegretol Chewtabs, Taro-Carbamazepine, Tegretol (TN), Prestwick_104, Equetro (TN), Carbamazepine [USAN:INN:BAN:JAN], Carbamazepine, powder, Taro-Carbamazepine Cr, Opera_ID_72, Spectrum_000096, Carbamazepine [USAN:USP:INN:BAN:JAN], Carbamazepine(Carbatrol), carbamazepine (Tegretol), AC1L1DXT, AC1Q4ZSU, AC1Q4ZSV, Prestwick0_000052, Prestwick1_000052, Prestwick2_000052, Prestwick3_000052, Spectrum2_000125, Spectrum3_000325, Spectrum4_000262, Spectrum5_000936, Carbamazepine (Carbatrol), Lopac-C-4024, ChemDiv1_018966, CBChromo1_000350, Epitope ID:174842, Iminostilbene-N-carboxamide, Lopac0_000292, Oprea1_790775, SCHEMBL21639, BSPBio_000203, BSPBio_001929, KBioGR_000724, KBioSS_000516, MLS001055475, MLS001074172, MLS002548877, BIDD:GT0479, DivK1c_000388, DivK1c_003750, SPECTRUM1500159, SPBio_000170, SPBio_002124, CARBAMAZEPINE, U.S.P., BPBio1_000225, GTPL5339, ZINC4785, DTXSID4022731, SCHEMBL19838283, HMS501D10, HMS640O02, KBio1_000388, KBio2_000516, KBio2_003084, KBio2_005652, KBio3_001149, WLN: T C676 BNJ BVZ, AOB5783, Carbamazepine (JP17/USP/INN), dibenz[b,f]azepine-5-carboxamide, SPD-417, Carbamazepine, analytical standard, NINDS_000388, HMS1568K05, HMS1920I17, HMS2090M07, HMS2091O19, HMS2095K05, HMS2233G16, HMS3039K09, HMS3259B21, HMS3260L06, HMS3372J13, HMS3657G03, HMS3712K05, Pharmakon1600-01500159, ACT02606, BCP21380, HY-B0246, KS-00000KI8, 5-Carbomoyl-5H-dibenzo(b,f)azepine, Tox21_110104, Tox21_202273, Tox21_300195, Tox21_500292, BBL005372, BDBM50003659, BG0497, CCG-38931, GP8250, NSC755920, s1693, STK177357, STL453548, 11-benzo[b][1]benzazepinecarboxamide, 5H-Dibenz[b,f]azepine-5-carboxamine, Carbamazepine 1.0 mg/ml in Methanol, AKOS003235644, AKOS025397243, IMED104589831, Tox21_110104_1, 5H-Dibenz[b,f]azepine-5- carboxamide, AC-9538, AN-6325, CS-2225, DB00564, KS-5146, LP00292, MCULE-9121567287, NC00679, NSC-169864, NSC-755920, 5H-Dibenz[ b, f]azepine-5-carboxamide, CDS1_002710, IDI1_000388, 5H-Dibenzo[b,f]azepine-5-carboxamide #, NCGC00015234-01, NCGC00015234-02, NCGC00015234-03, NCGC00015234-04, NCGC00015234-05, NCGC00015234-06, NCGC00015234-07, NCGC00015234-08, NCGC00015234-09, NCGC00015234-10, NCGC00015234-12, NCGC00015234-13, NCGC00015234-14, NCGC00015234-15, NCGC00015234-16, NCGC00015234-19, NCGC00023877-03, NCGC00023877-04, NCGC00023877-05, NCGC00023877-06, NCGC00023877-07, NCGC00023877-08, NCGC00253982-01, NCGC00259822-01, NCGC00260977-01, AJ-08227, AJ-08230, BC200975, CC-25382, CC-25383, CPD001227191, H495, LS-60362, SAM002264603, SC-16243, ST075773, SY002823, ZB000594, (z)-5h-dibenzo[b,f]azepine-5-carboxamide, SBI-0050280.P004, 5H-dibenzo[b,f]azepine-5-carboximidic acid, AB0070254, AB1009530, ST2418853, EU-0100292, FT-0602927, FT-0696814, H2605, SW220141-1, EN300-21678, BIM-0050280.0001, C 4024, C06868, Carbamazepine, meets USP testing specifications, D00252, AB00051931-17, AB00051931-18, AB00051931_19, AB00051931_20, MFCD00005073 (97+%), A820074, C-13993, I06-0863, SR-01000000229-2, SR-01000000229-4, SR-01000000229-7, BRD-K71799949-001-06-7, F0348-2551, Z2199879032, Dibenzo[b,f]azepine-5-carboxylic acid amide(Carbamazepine), Carbamazepine, British Pharmacopoeia (BP) Reference Standard, Carbamazepine, European Pharmacopoeia (EP) Reference Standard, Carbamazepine, United States Pharmacopeia (USP) Reference Standard, 2-azatricyclo[9.4.0.0;{3,8}]pentadeca-1(11),3(8),4,6,9,12,14-heptaene-2-carboxamide, Carbamazepine solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Carbamazepine, Pharmaceutical Secondary Standard; Certified Reference Material, Azapentacene; Sodium 5,12-dihydroazapentacene disulfonate; 5,12-Dihydroquinoxalino[2,3-b]phenazine sulfonate sodium salt, captopril, Carbamazepine-D10, Tegretol XR, Carbamazepine dihydrate, Carbamazepine Anhydrous, Carbamazepine Phosphate, carbamazepine hydrate, carbamazepine sulfate, Carbamazepine Acetate, carbamazepine tartrate, Carbamazepine Hydrochloride, D04MSM, C15H12N2O, Carbamazepine (iv, epilepsy), Carbamazepine Sulfate (2:1), Carbamazepine L-Tartrate (4:1), CID2554, c1095, C15-H12-N2-O, Carbamazepine [USAN:BAN:INN:JAN], Carbamazepine (iv, epilepsy), Lundbeck, Carbamazepine, 98% - 100G 100g, CS-O-07528, 5H-Dibenz[b,f]-nu-azepine-5-carboxamide, B1390, 5-20-08-00247 (Beilstein Handbook Reference), A10179, Carbamazepine (<lt/> 100 microg/ml) in methanol, D002220, Carbamazepine (iv, epilepsy), Ovation Pharmaceuticals, Carbamazepine, 97%, a sodium channel blocker - 1g 1g,

Complexity	326
Compound Is Canonicalized	Yes
Covalently-Bonded Unit Count	1
Defined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Exact Mass	236.095g/mol
Formal Charge	0
Heavy Atom Count	18
Hydrogen Bond Acceptor Count	1
Hydrogen Bond Donor Count	1
Isotope Atom Count	0
Molecular Weight	236.274g/mol
Monoisotopic Mass	236.095g/mol
Rotatable Bond Count	0
Topological Polar Surface Area	46.3A^2
Undefined Atom Stereocenter Count	0
Undefined Bond Stereocenter Count	0
XLogP3	2.5

GHS Hazard and Precautionary Statements

Symbol:
Hazard Class
Hazard statements	H302-H315-H319-H335-H350-H360
Packing Group
Precautionary statements	P261-P305+P351+P338
UN Code

Certificate of Analysis

Lot Number